|
"lee teng yu"的相關文件
顯示項目 1-25 / 29 (共2頁) 1 2 > >> 每頁顯示[10|25|50]項目
中山醫學大學 |
2021-07 |
Liver Injury in Liver Transplant Patients With COVID-19: A Histopathologic Analysis Reply
|
Lee, Teng-Yu; Wu, Chun-Ying |
中山醫學大學 |
2021-06 |
Once-daily tenofovir disoproxil fumarate in treatment-naive Taiwanese patients with chronic hepatitis B and minimally raised alanine aminotransferase (TORCH-B): a multicentre, double-blind, placebo-controlled, parallel-group, randomised trial
|
Hsu Yao-Chun;Chen, Chi-Yi;Chang I-Wei;Chang Chi-Yang;Wu Chun-Ying;Lee Teng-Yu;Wu Ming-Shiang;Bair Ming-Jong; Chen Jyh-Jou; Chen Chieh-Chang; Tseng Cheng-Hao; Tai Chi-Ming; Huang Yen-Tsung; Ku Wen-Hui; Mo Lein-Ray; Lin Jaw-Town |
臺大學術典藏 |
2021-03-14T23:24:22Z |
Once-daily tenofovir disoproxil fumarate in treatment-naive Taiwanese patients with chronic hepatitis B and minimally raised alanine aminotransferase (TORCH-B): a multicentre, double-blind, placebo-controlled, parallel-group, randomised trial
|
Hsu, Yao Chun; Chen, Chi Yi; Chang, I. Wei; Chang, Chi Yang; Wu, Chun Ying; Lee, Teng Yu; MING-SHIANG WU; Bair, Ming Jong; Chen, Jyh Jou; Chen, Chieh Chang; Tseng, Cheng Hao; Tai, Chi Ming; Huang, Yen Tsung; Ku, Wen Hui; Mo, Lein Ray; Lin, Jaw Town |
臺大學術典藏 |
2021-03-05T08:32:11Z |
Once-daily tenofovir disoproxil fumarate in treatment-naive Taiwanese patients with chronic hepatitis B and minimally raised alanine aminotransferase (TORCH-B): a multicentre, double-blind, placebo-controlled, parallel-group, randomised trial
|
Hsu, Yao-Chun; Chen, Chi-Yi; Chang, I-Wei; Chang, Chi-Yang; Wu, Chun-Ying; Lee, Teng-Yu; Wu, Ming-Shiang; Bair, Ming-Jong; Chen, Jyh-Jou; CHIEH-CHANG CHEN; Tseng, Cheng-Hao; Tai, Chi-Ming; Huang, Yen-Tsung; Ku, Wen-Hui; Mo, Lein-Ray; Lin, Jaw-Town |
中山醫學大學 |
2020-07 |
Impact of Glutathione and Vitamin B-6 in Cirrhosis Patients: A Randomized Controlled Trial and Follow-Up Study
|
Lai, Chia-Yu; Cheng, Shao-Bin; Lee, Teng-Yu; Hsiao, Yung-Fang; Liu, Hsiao-Tien; Huang, Yi-Chia |
中山醫學大學 |
2020-05 |
Hepatitis B flare during osimertinib targeted therapy in a lung cancer patient with a resolved hepatitis B virus infection
|
Lee, Po-Hsin;Lee, Teng-Yu;Chang, Gee-Chen |
中山醫學大學 |
2020-03-30 |
Atorvastatin-induced senescence of hepatocellular carcinoma is mediated by downregulation of hTERT through the suppression of the IL-6/STAT3 pathway
|
Wang, Sin-Ting;Huang, Shi-Wei;Liu, Kuang-Ting;Lee, Teng-Yu;Shieh, Jeng-Jer;Wu, Chun-Ying |
中山醫學大學 |
2019-11 |
Sorafenib treatment on Chinese patients with advanced hepatocellular carcinoma: A study on prognostic factors of the viral and tumor status
|
Lee, Shou-Wu;Lee, Teng-Yu;Peng, Yen-Chun;Yang, Sheng-Shun;Yeh, Hong-Zen;Chang, Chi-Sen |
中山醫學大學 |
2018-11 |
The choice of antiviral therapy for hepatitis C recurrence after liver transplantation in the real world
|
Lee, Teng-Yu;Yang, Sheng-Shun |
臺大學術典藏 |
2018-09-10T09:51:59Z |
A nationwide population-based study shows increasing incidence of cholangiocarcinoma
|
Lee, Teng-Yu;Lin, Jaw-Town;Kuo, Ken N.;Wu, Ming-Shiang;Ho, Hsiu J.;Chen, Tzu-Ting;Wu, Chun-Ying; Lee, T.-Y. and Lin, J.-T. and Kuo, K.N. and Wu, M.-S. and Ho, H.J. and Chen, T.-T. and Wu, C.-Y.; 林肇堂 ;吳明賢; MING-SHIANG WU; Lee, Teng-Yu; Lin, Jaw-Town; Kuo, Ken N.; Wu, Ming-Shiang; Ho, Hsiu J.; Chen, Tzu-Ting; Wu, Chun-Ying |
臺大學術典藏 |
2018-09-10T09:40:38Z |
Hepatic resection for hepatocellular carcinoma patients on hemodialysis for Uremia: A nationwide cohort study
|
Yeh, C.-C. and Lin, J.-T. and Jeng, L.-B. and Charalampos, I. and Chen, T.-T. and Lee, T.-Y. and Wu, M.-S. and Kuo, K.N. and Liu, Y.-Y. and Wu, C.-Y.; Yeh, Chun-Chieh;Lin, Jaw-Town;Jeng, Long-Bin;Charalampos, Iakovidis;Chen, Tzu-Ting;Lee, Teng-Yu;Wu, Ming-Shiang;Kuo, Ken N.;Liu, Yi-Ya;Wu, Chun-Ying; 林肇堂 ;吳明賢; MING-SHIANG WU; Yeh, Chun-Chieh; Lin, Jaw-Town; Jeng, Long-Bin; Charalampos, Iakovidis; Chen, Tzu-Ting; Lee, Teng-Yu; Wu, Ming-Shiang; Kuo, Ken N.; Liu, Yi-Ya; Wu, Chun-Ying |
臺大學術典藏 |
2018-09-10T09:40:38Z |
Osteopontin promoter polymorphisms are associated with susceptibility to gastric cancer
|
Lee, Teng-Yu;Lin, Jaw-Town;Wu, Cheng-Chung;Yu, Cheng-Chan;Wu, Ming-Shiang;Lee, Tso-Ching;Chen, Hsiao-Ping;Wu, Chun-Ying; Lee, T.-Y. and Lin, J.-T. and Wu, C.-C. and Yu, C.-C. and Wu, M.-S. and Lee, T.-C. and Chen, H.-P. and Wu, C.-Y.; 吳明賢; MING-SHIANG WU; Lee, Teng-Yu; Lin, Jaw-Town; Wu, Cheng-Chung; Yu, Cheng-Chan; Wu, Ming-Shiang; Lee, Tso-Ching; Chen, Hsiao-Ping; Wu, Chun-Ying |
中山醫學大學 |
2018-08 |
Development of a scoring system to predict hepatocellular carcinoma in Asians on antivirals for chronic hepatitis B
|
Hsu, Yao-Chun;Terry, Cheuk-FungYip;Ho, Hsiu J.;Wong, Vincent Wai-Sun;Huang, Yen-Tsung;Hashem, B.El-Serag;Lee, Teng-Yu;Wu, Ming-Shiang;Lin, Jaw-Town;Wong, Grace Lai-Hung;Wu, Chun-Ying |
中山醫學大學 |
2018-06 |
Effect of Nucleos(t)ide Analogue Therapy on Risk of Intrahepatic Cholangiocarcinoma in Patients With Chronic Hepatitis B
|
Lee, Teng-Yu;Hsu, Yao-Chun;Yu, Shi-Hang;Lin, Jaw-Town;Wu, Ming-Shiang;Wu, Chun-Ying |
中山醫學大學 |
2018-05-27 |
Possible Synergistic Effects of Glutathione and C-Reactive Protein in the Progression of Liver Cirrhosis
|
Lai, Chia-Yu;Cheng, Shao-Bin;Lee, Teng-Yu;Liu, Hsiao-Tien;Huang, Shih-Chien;Huang, Yi-Chia |
中山醫學大學 |
2018-05 |
Temporal trend and risk determinants of hepatocellular carcinoma in chronic hepatitis B patients on entecavir or tenofovir
|
Hsu, Yao-Chun;Ho, Hsiu-J;Lee, Teng-Yu;Huang, Yen-Tsung;Wu, Ming-Shiang;Lin, Jaw-Town;Wu, Chun-Ying;Hashem, B El-Serag |
中山醫學大學 |
2018-01-01 |
The ultra-short virological dynamics in response to entecavir or lamivudine during chronic hepatitis B with spontaneous severe acute exacerbation
|
Lee, Teng-Yu;Chen, Chi-Yi;Lia, Hsueh-Chou;Hsu, Yu-Chung;Yang, Sheng-Shun |
中山醫學大學 |
2017-12 |
Lamivudine versus entecavir in the rescue of chemotherapy-induced hepatitis B flare-up
|
Liao, Yi-Jun;Li, Yen-Chang;Lee, Shou-Wu;Wu, Chun-Ying;Yang, Sheng-Shun;Yeh, Hong-Zen;Chang, Chi-Sen;Lee, Teng-Yu |
中山醫學大學 |
2017-11-30 |
Transcatheter arterial chemoembolization after stopping sorafenib therapy for advanced hepatocellular carcinoma
|
Huang, Yao-Kuang;Yen, Chieh-Ling;Shiu, Sz-Iuan;Lee, Shou-Wu;Chang, Pi-Yi;Yeh, Hong-Zen;Lee, Teng-Yu |
中山醫學大學 |
2017-10-01 |
The occurrence of hepatocellular carcinoma in different risk stratifications of clinically noncirrhotic nonalcoholic fatty liver disease
|
Lee, Teng-Yu;Wu, Jaw-Ching;Yu, Shi-Hang;Lin, Jaw-Town;Wu, Ming-Shiang;Wu, Chun-Ying |
中山醫學大學 |
2017-09 |
Combination of transcatheter arterial chemoembolization and interrupted dosing sorafenib improves patient survival in early–intermediate stage hepatocellular carcinoma A post hoc analysis of the START trial
|
Lee, Teng-Yu;Lin, Chen-Chun;Chen, Chiung-Yu;Wang, Tsang-En;Lo, Gin-Ho;Chang, Chi-Sen;Yee, Chao |
中山醫學大學 |
2017-06 |
Oral Direct Acting Antivirals treatment failed to cure a patient with chronic hepatitis C due to shifts of viral genotype
|
Lee, Shou-Wu;Yang, Sheng-Shun;Lee, Teng-Yu;Yeh, Hong-Zen;Lu, I-Ta;Chang, Chi-Sen |
中山醫學大學 |
2017-05-15 |
Impact of Obesity on a Chinese Population with Erosive Esophagitis and Barrett's Esophagus
|
Lee, Shou-Wu;Lien, Han-Chung;Lee, Teng-Yu;Tung, Chun-Fang;Yeh, Hong-Zen;Chang, Chi-Sen |
國立成功大學 |
2014-06-13 |
Development of a Highly Sensitive Glycan Microarray for Quantifying AFP-L3 for Early Prediction of Hepatitis B Virus-Related Hepatocellular Carcinoma
|
Wu, Chen-Shiou; Lee, Teng-Yu; Chou, Ruey-Hwang; Yen, Chia-Jui; Huang, Wei-Chien; Wu, Chung-Yi; Yu, Yung-Luen |
國立成功大學 |
2014 |
Consensus on Control of Risky Nonvariceal Upper Gastrointestinal Bleeding in Taiwan with National Health Insurance
|
Sheu, Bor-Shyang; Wu, Chun-Ying; Wu, Ming-Shiang; Chiu, Cheng-Tang; Lin, Chun-Che; Hsu, Ping-I; Cheng, Hsiu-Chi; Lee, Teng-Yu; Wang, Hsiu-Po; Lin, Jaw-Town |
顯示項目 1-25 / 29 (共2頁) 1 2 > >> 每頁顯示[10|25|50]項目
|